P8G-25982-56277
3 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 906 / CA
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-20
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
-
2021-04-10
Dose 2 — Pfizer-BioNTech
- 2021-04-10
- 2021-04-11
- 2021-04-12
-
2021-04-13
Survey response — days 1–6 daily, dose 2MedDRA: Anxiety, Depression — Feeling: GoodFree text: Anxiety/depressionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-26
-
2021-10-10
Dose 3 — Pfizer-BioNTech
- 2021-10-11
-
2021-10-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-10-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Pfizer-BioNTech | |
| 2 | 2021-04-10 | Pfizer-BioNTech | |
| 3 | 2021-10-10 | Pfizer-BioNTech | No |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Anxiety/depression
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Anxiety | ✓ | ✓ | ✓ |
| SRO | Depression | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release